Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Páez-Franco JC, González-Sánchez I, Gutiérrez-Nájera NA, Valencia-Turcotte LG, Lira-Rocha A, Cerbón MA, Rodríguez-Sotres R. Proteomic Profiling Reveals the Induction of UPR in Addition to DNA Damage Response in HeLa Cells Treated With the Thiazolo[5,4-b]Quinoline Derivative D3ClP. J Cell Biochem 2016;118:1164-1173. [DOI: 10.1002/jcb.25753] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2016] [Accepted: 09/28/2016] [Indexed: 12/27/2022]

For:	Páez-Franco JC, González-Sánchez I, Gutiérrez-Nájera NA, Valencia-Turcotte LG, Lira-Rocha A, Cerbón MA, Rodríguez-Sotres R. Proteomic Profiling Reveals the Induction of UPR in Addition to DNA Damage Response in HeLa Cells Treated With the Thiazolo[5,4-b]Quinoline Derivative D3ClP. J Cell Biochem 2016;118:1164-1173. [DOI: 10.1002/jcb.25753] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2016] [Accepted: 09/28/2016] [Indexed: 12/27/2022]

Number	Cited by Other Article(s)
1	HHQ-4, a quinoline derivate, preferentially inhibits proliferation of glucose-deprived breast cancer cells as a GRP78 down-regulator. Toxicol Appl Pharmacol 2019;373:10-25. [DOI: 10.1016/j.taap.2019.04.017] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2018] [Revised: 04/18/2019] [Accepted: 04/19/2019] [Indexed: 01/13/2023] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

HHQ-4, a quinoline derivate, preferentially inhibits proliferation of glucose-deprived breast cancer cells as a GRP78 down-regulator. Toxicol Appl Pharmacol 2019;373:10-25. [DOI: 10.1016/j.taap.2019.04.017] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2018] [Revised: 04/18/2019] [Accepted: 04/19/2019] [Indexed: 01/13/2023]